<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ELIMITE- permethrin cream </strong><br>Prestium Pharma, Inc.<br></p></div>
<h1><span class="Bold">ELIMITE™ CREAM </span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_6773cb74-e5cf-40b7-aa6c-ea91033aa85d"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">ELIMITE™ (permethrin) 5% Cream is a topical scabicidal agent for the treatment of <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span> with <span class="Italics">Sarcoptes</span><span class="Italics"></span><span class="Italics">scabiei</span> (<span class="product-label-link" type="condition" conceptid="140949" conceptname="Infestation by Sarcoptes scabiei var hominis">scabies</span>). It is available in an off-white, vanishing cream base. ELIMITE™ (permethrin) 5% Cream is for topical use only.</p>
<div class="Figure">
<a name="id29716140"></a><img alt="Image 1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4de55a80-67d6-42c0-a6fc-57b89400c5b3&amp;name=4de55a80-67d6-42c0-a6fc-57b89400c5b3-01.jpg">
</div>
<p><span class="Bold">Chemical Name</span> - The permethrin used is an approximate 1:3 mixture of the cis and trans isomers of the pyrethroid 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl) methyl ester. Permethrin has a molecular formula of C<span class="Sub">21</span>H<span class="Sub">20</span>Cl<span class="Sub">2</span>O<span class="Sub">3</span> and a molecular weight of 391.29. It is a yellow to light orange-brown, low melting solid or viscous liquid.</p>
<p><span class="Bold">Active Ingredient</span> - Each gram contains permethrin 50 mg (5%).</p>
<p><span class="Bold">Inactive Ingredients</span> - Butylated hydroxytoluene, carbomer homopolymer type B, fractionated coconut oil, glycerin, glyceryl monostearate, isopropyl myristate, lanolin alcohols, mineral oil, polyoxyethylene cetyl ethers, purified water, and sodium hydroxide. Formaldehyde 1 mg (0.1%) is added as a preservative.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_271e353c-aa18-464e-a3ac-34a48c95cf7a"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Permethrin, a pyrethroid, is active against a broad range of pests including lice, ticks, fleas, mites, and other arthropods. It acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span> of the pests are the consequences of this disturbance.</p>
<p>Permethrin is rapidly metabolized by ester hydrolysis to inactive metabolites which are excreted primarily in the urine. Although the amount of permethrin absorbed after a single application of the 5% cream has not been determined precisely, data from studies with <span class="Sup">14</span>C-labeled permethrin and absorption studies of the cream applied to patients with moderate to severe <span class="product-label-link" type="condition" conceptid="140949" conceptname="Infestation by Sarcoptes scabiei var hominis">scabies</span> indicate it is 2% or less of the amount applied.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_8d24af36-07f4-4450-af61-59271c1eefdc"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">ELIMITE™ (permethrin) 5% Cream is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span> with <span class="Italics">Sarcoptes</span><span class="Italics"></span><span class="Italics">scabiei</span> (<span class="product-label-link" type="condition" conceptid="140949" conceptname="Infestation by Sarcoptes scabiei var hominis">scabies</span>).</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ID_3e06c014-4f59-4e37-8180-88cb7be25cce"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">ELIMITE™ (permethrin) 5% Cream is contraindicated in patients with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of its components, to any synthetic pyrethroid or pyrethrin.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_055a9299-4fe6-4544-b385-07f68b4c89ae"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">If <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to ELIMITE™ (permethrin) 5% Cream occurs, discontinue use.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_74776b06-6ec1-4be7-9b25-bc15b5af71e3"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Click here to enter Precautions</p>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_6c1f196d-50de-4a5f-9e8c-232ceb8e8b83"></a><a name="section-6.1"></a><p></p>
<h2>General -</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="140949" conceptname="Infestation by Sarcoptes scabiei var hominis">Scabies infestation</span> is often accompanied by <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, and <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>. Treatment with ELIMITE™ (permethrin) 5% Cream may temporarily exacerbate these conditions.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="ID_f328851c-19c4-423f-8c3c-bcb08c826ead"></a><a name="section-6.2"></a><p></p>
<h2>Information for Patients -</h2>
<p class="First">Patients with <span class="product-label-link" type="condition" conceptid="140949" conceptname="Infestation by Sarcoptes scabiei var hominis">scabies</span> should be advised that <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, mild burning and/or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> may occur after application of ELIMITE™ (permethrin) 5% Cream. In clinical trials, approximately 75% of patients treated with ELIMITE™ (permethrin) 5% Cream who continued to manifest <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> at 2 weeks had cessation by 4 weeks. If irritation persists, they should consult their physician. ELIMITE™ (permethrin) 5% Cream may be very mildly irritating to the eyes. Patients should be advised to avoid contact with eyes during application and to flush with water immediately if ELIMITE™ (permethrin) 5% Cream gets in the eyes.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_35ecdd9c-3580-4a32-b6e7-98286f7b8406"></a><a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility -</h2>
<p class="First">Six carcinogenicity bioassays were evaluated with permethrin, three each in rats and mice. No tumorigenicity was seen in the rat studies. However, species-specific increases in pulmonary <span class="product-label-link" type="condition" conceptid="4106411" conceptname="Adenofibroma">adenomas</span>, a common benign tumor of mice of high spontaneous background incidence, were seen in the three mouse studies. In one of these studies there was an increased incidence of pulmonary alveolar-cell carcinomas and benign liver <span class="product-label-link" type="condition" conceptid="4106411" conceptname="Adenofibroma">adenomas</span> only in female mice when permethrin was given in their food at a concentration of 5000 ppm. Mutagenicity assays, which give useful correlative data for interpreting results from carcinogenicity bioassays in rodents, were negative. Permethrin showed no evidence of mutagenic potential in a battery of <span class="Italics">in vitro</span> and <span class="Italics">in vivo</span> genetic toxicity studies.</p>
<p>Permethrin did not have any adverse effect on reproductive function at a dose of 180 mg/kg/day orally in a three-generation rat study.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_df41ec3c-273a-42d4-9f2d-cfe9cfc2c3b3"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy:</h2>
<p class="First">[Enter Pregnancy here]</p>
<div class="Section" data-sectionCode="34077-8">
<a name="ID_ee76ca16-270f-48cf-874e-409c8d24977b"></a><a name="section-6.4.1"></a><p></p>
<h3>
<span class="Italics">Teratorgenic</span><span class="Italics"> Effects:</span>
</h3>
<p class="First">[Enter Teratorgenic Effects here]</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_d60018fc-bffd-4de3-a4bb-6b4236f30a52"></a><a name="section-6.4.1.1"></a><p></p>
<h4><span class="Italics">Pregnancy Category B - </span></h4>
<p class="First">Reproduction studies have been performed in mice, rats, and rabbits (200 to 400 mg/kg/day orally) and have revealed no evidence of impaired fertility or harm to the fetus due to permethrin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_df7e8551-b245-4d95-a497-cdd006f59cd5"></a><a name="section-6.5"></a><p></p>
<h2>Nursing Mothers -</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the evidence for tumorigenic potential of permethrin in animal studies, consideration should be given to discontinuing nursing temporarily or withholding the drug while the mother is nursing.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="ID_f70d6083-10ff-4338-8a44-8306f1c8bdd6"></a><a name="section-6.6"></a><p></p>
<h2>Pediatric Use -</h2>
<p class="First">ELIMITE™ (permethrin) 5% Cream is safe and effective in pediatric patients two months of age and older. Safety and effectiveness in infants less than two months of age have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="ID_a7626467-fce7-43b7-8df7-04a5d01ca453"></a><a name="section-6.7"></a><p></p>
<h2>Geriatric Use -</h2>
<p class="First">Clinical studies of ELIMITE™ (permethrin) 5% Cream did not identify sufficient numbers of subjects aged 65 and over to allow a definitive statement regarding whether elderly subjects respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. This drug is known to be substantially excreted by the kidney. However, since topical permethrin is metabolized in the liver and excreted in the urine as inactive metabolites, there does not appear to be an increased risk of toxic reactions in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span> when used as labeled.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_230918ff-dace-417a-b9ca-9648df3bf154"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">In clinical trials, generally mild and transient burning and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> followed application with ELIMITE™ (permethrin) 5% Cream in 10% of patients and was associated with the severity of <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span>. <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span> was reported in 7% of patients at various times post-application. <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">Erythema</span>, <span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">numbness</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span>, and <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> were reported in 1 to 2% or less of patients (see <span class="Bold">PRECAUTIONS - General</span>). Other adverse events reported since marketing ELIMITE™ (permethrin) 5% Cream include: <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> and <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and/or <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. Although extremely uncommon and not expected when used as directed (see <span class="Bold">DOSAGE AND ADMINISTRATION</span>), rare occurrences of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> have been reported. None have been medically confirmed as associated with ELIMITE™ treatment.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="ID_a55ad744-5d59-4d0d-a6fc-7830d825c3a5"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">No instance of accidental ingestion of ELIMITE™ (permethrin) 5% Cream has been reported. If ingested, gastric lavage and general supportive measures should be employed. Excessive topical use (see <span class="Bold">DOSAGE AND ADMINISTRATION</span>) may result in increased irritation and <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="ID_ec5c74b8-3718-4c0a-bb7c-8c65f5e67bef"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><span class="Bold">Adults and children</span> - Thoroughly massage ELIMITE™ (permethrin) 5% Cream into the skin from the head to the soles of the feet. <span class="product-label-link" type="condition" conceptid="140949" conceptname="Infestation by Sarcoptes scabiei var hominis">Scabies</span> rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on the scalp, temple, and forehead. <span class="Bold">ONE APPLICATION IS GENERALLY CURATIVE.</span></p>
<p>Patients may experience persistent <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> after treatment. This is rarely a sign of treatment failure and is not an indication for retreatment. Demonstrable living mites after 14 days indicate that retreatment is necessary.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_6f9cdccc-17f3-459c-ae91-30b2922779cb"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">ELIMITE™ 5% Cream is available as follows: </p>
<p>60 g tube (<span class="Bold">NDC</span> 40076-115-60)</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="ID_a54338fc-3284-4ad1-9d0d-665de4073649"></a><a name="section-11"></a><p></p>
<h1>STORAGE</h1>
<p class="First">Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_56d10c3d-2d4f-4bc7-af8d-6639a937777f"></a><a name="section-12"></a><p></p>
<h1>Click here to enter text.</h1>
<div class="Figure">
<a name="id29718476"></a><img alt="Image 2" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4de55a80-67d6-42c0-a6fc-57b89400c5b3&amp;name=4de55a80-67d6-42c0-a6fc-57b89400c5b3-02.jpg">
</div>
<p class="First">Manufactured for Prestium Pharma, Inc.</p>
<p>Newtown, PA 18940</p>
<p>by Perrigo Pharmaceuticals, Allegan, MI 49010</p>
<p>Rev. 07/12</p>
<p>1T600 ZH J1</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_8fdd7c63-a698-4fe1-8e6b-280aba9ec21d"></a><a name="section-13"></a><p></p>
<h1>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL- Carton</h1>
<p class="First">ELIMITE™ CREAM</p>
<p>(PERMETHRIN) 5%*</p>
<p>*W/W</p>
<p>FOR EXTERNAL USE ONLY. NOT FOR USE IN EYES.</p>
<p>Rx Only</p>
<div class="Figure">
<a name="id29718665"></a><img alt="Elimite (TM) Cream Carton Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4de55a80-67d6-42c0-a6fc-57b89400c5b3&amp;name=4de55a80-67d6-42c0-a6fc-57b89400c5b3-03.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_abe2c43c-847b-4ca2-800f-6ddaa8518d71"></a><a name="section-14"></a><p></p>
<h1>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL- Tube</h1>
<p class="First">ELIMITE™ CREAM</p>
<p>(PERMETHRIN) 5%*</p>
<p>*W/W</p>
<p>FOR EXTERNAL USE ONLY. NOT FOR USE IN EYES.</p>
<p>Rx Only</p>
<div class="Figure">
<a name="id29718668"></a><img alt="Elimite (TM) Cream Tube Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4de55a80-67d6-42c0-a6fc-57b89400c5b3&amp;name=4de55a80-67d6-42c0-a6fc-57b89400c5b3-04.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ELIMITE 		
					</strong><br><span class="contentTableReg">permethrin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:40076-115</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PERMETHRIN</strong> (PERMETHRIN) </td>
<td class="formItem">PERMETHRIN</td>
<td class="formItem">50 mg  in 100 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MEDIUM-CHAIN TRIGLYCERIDES</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERYL MONOSTEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LANOLIN ALCOHOLS</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MINERAL OIL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FORMALDEHYDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:40076-115-60</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">60 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA076369</td>
<td class="formItem">10/24/2012</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Prestium Pharma, Inc.
							(078304674)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 11/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>4de55a80-67d6-42c0-a6fc-57b89400c5b3</div>
<div>Set id: 4de55a80-67d6-42c0-a6fc-57b89400c5b3</div>
<div>Version: 1</div>
<div>Effective Time: 20121120</div>
</div>
</div> <div class="DistributorName">Prestium Pharma, Inc.</div></p>
</body></html>
